A study led by researchers at Beth Israel Deaconess Medical Center (BIDMC), in collaboration with scientists at Walter Reed Army Institute of Research (WRAIR), Janssen Vaccines & Prevention B.V., one of the Janssen Pharmaceutical ...
Nov 9, 2016
0
25
Transplanted pancreatic islets in diabetic animals can survive for a long period of time if the animals are treated with short anti-rejection therapy around the time of the transplant. This has been shown by researchers at ...
Feb 1, 2019
0
13
A major clinical trial, led by experts at the University of Nottingham working in partnership with several universities and NHS hospitals, has found that interrupting the treatment of vulnerable people on long-term immune-suppressing ...
Jun 27, 2022
0
59
Interactions between cells of the immune system and pre-cancerous cells are known to be important contributing factors to the initiation and progression of cancer. However, the dynamics of these interactions have not been ...
Apr 7, 2022
0
93
A new multidrug treatment for patients with stage IV melanoma has proven effective after a three-year clinical trial at the University of Colorado Cancer Center.
Dec 16, 2022
0
29
Johns Hopkins researchers have invented a new class of immunotherapeutic agents that are more effective at harnessing the power of the immune system to fight cancer. Their approach results in significant inhibition of tumor ...
Feb 22, 2018
0
78
The immune system is normally known for protecting the body from illness. But a subset of immune cells appear to be doing more harm than good.
Sep 5, 2013
0
0
A provocative study links prolonged episodes of sepsis—a life-threatening infection and leading cause of death in hospitals—to the reactivation of otherwise dormant viruses in the body.
Jun 11, 2014
0
0
Short bursts of radiation therapy dramatically enhanced the efficiency of targeting glioblastomas with natural nanoparticle-based immunotherapy, thus suppressing growth of the deadly tumor, inducing anti-tumor immunity and ...
Jan 31, 2022
0
135
Researchers at University of California San Diego School of Medicine and Moores Cancer Center have identified a strategy to maximize the effectiveness of anti-cancer immune therapy. The researchers identified a molecular ...
Sep 19, 2016
0
119
